Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic ICEme Kits

Transgenomic has launched its ICEme Mutation Enrichment Kits for cancer biomarker research. The kits are based on the company's ICE COLD-PCR technology, which preferentially enriches mutant DNA sequences in an excess of wild-type DNA through selective amplification of the mutant DNA. The company said the kits are customizable, and the initial menu includes 17 clinically relevant, actionable mutations that are associated with important cancers.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.